Burkhart Erin reported option exercise involving 2,223 shares of GILEAD SCIENCES, INC. on Sep 22, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SVP, Controllership
SVP, Controllership
Filed Sep 23, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
2,223Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,223Direct
Trade date
Sep 22, 2026Option exercise
Filed
Sep 23, 2026, 4:17 PM ET1-day reporting delay
Accession
0001927648-26-000005Code M · Transaction 228299
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 22, 2026Tax withholding768$152.67−$117,250.56Trade 228300
Sep 22, 2026Option exercise2,223——Trade 228301
3 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

GILD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GILD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −3.5%1w ago −3.3%1d ago −0.5%
Returns since7d −1.5%30d +3.8%90d180d1y

Footnotes in full

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.